hsCRP (high-sensitivity C-reactive protein) is a well-established marker of systemic inflammation. In the context of weight loss, obesity is associated with chronically elevated hsCRP due to adipose tissue inflammation. Observational evidence indicates that a 5–10% reduction in body weight can significantly lower hsCRP levels. However, the provided context fragments do not contain direct evidence for this link. The only mention is the rs1130864 variant in the CRP gene, which is rated as unclear in clinical significance – it neither causes elevated hsCRP nor predicts diet success. Therefore, the evidence for hsCRP in weight loss is 'mixed': mechanistic and epidemiological support exists, but no strong randomized trials are present in the given context. Practically, hsCRP can serve as a monitoring biomarker to track inflammation reduction through lifestyle changes. Genetic testing for CRP variants is not clinically indicated. Caveat: acute infections or other inflammatory sources must be ruled out before interpretation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-6283a01e05423cc29edc459f